{"name":"Geron Corporation","slug":"geron-corporation","ticker":"","exchange":"","domain":"","description":"Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":1065000,"revenueGrowth":457.6,"grossMargin":0,"rdSpend":0,"netIncome":-83500000,"cash":570540000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2017"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNMFNIeFdkcjQ2dzBmVlQ2LTQtbzhuaDlYRXNfTy1scHhBMEdGQ0NWYUJCalNZUzUycnVEZ3Bxc2ZpQnNqYlpOdkR3VE9jMzlrRXlKT0tGS3pxZ05CYUJuWS1lLVczM3RTZV9pRV96UjVrTF8wak5EWDU5MDBYZmpOdHZSNDBJR3BpdGE4QzdFLVp0b1VhRzlicm5aQTJoOXhiSEl6Ylkxalp5NndGRVRyZUtzS2JGOU8wUkR6LQ?oc=5","date":"2026-03-26","type":"pipeline","source":"Sahm","summary":"Geron Announces Appointment of New Members to its Board of Directors - Sahm","headline":"Geron Announces Appointment of New Members to its Board of Directors","sentiment":"neutral"},{"date":"2026-03-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9UMG5mMUdWbk5Ma2VCMi1xWHdTcEp0ME4xZHR5WEdodFlyMGVXTS1xRDNHNEo1eUZVU2hOdWVpUV9OOUVyclFyd200b200THpOdVNYUjhqSmtWMUhCaVHSAWNBVV95cUxORWdJSGk0dXZRNlRGU3dpLXppR0hId1RoMFNGWmNLZ3M0Wk1lcGFlOFFJTUVUa2dFTnlhLXBIZ3pfdUV4SEpiYlFhY0RuWjU0TWlHM0Fsb25LR3lfT2d6ZUota1k?oc=5","date":"2026-03-25","type":"pipeline","source":"Bitget","summary":"Geron Announces Appointment of New Members to its Board of Directors - Bitget","headline":"Geron Announces Appointment of New Members to its Board of Directors","sentiment":"neutral"},{"date":"2026-03-02","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFA2LWlIZmNhR1FobktueXhyb1N2S2hleDJiSk1ZY1daaExZNlJZZlhnUUZ0ckVuUHl6VGlfVy0wNFhCWWhNYy1MUmNHN2d2Wk1ZRmx1MjBna3RRVjZtQVRiMm8tZ2IzdTFEMkxSaVNIaUd2YW80NVNMSQ?oc=5","date":"2025-12-12","type":"pipeline","source":"PharmaLive","summary":"Pfizer, Geron downsize to streamline costs - PharmaLive","headline":"Pfizer, Geron downsize to streamline costs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPZFBDZ3ZiQXdFZnIwTWRfQ1UtVFZ0MlVxUmZFMDdJQkNiZ2ZELVp4WkxLWUFtWnNrZWdJeC1wcnF6aDVQeVNLeXdaVjJRaHhOcWx2bW1Lc3NfNkxLdjl3a0tpck1ISHRremJvWFQtTURPMHpZWjE1c2JVd08zd0lscUV6U08wWDA5UDZCSzRUUV9fOFVOSjF6b2hkNU50b2g0blR1OS01WDdnNGNXMXc?oc=5","date":"2025-12-11","type":"pipeline","source":"Fierce Pharma","summary":"Geron to lay off 3rd of workforce in bid to slash operating costs - Fierce Pharma","headline":"Geron to lay off 3rd of workforce in bid to slash operating costs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNVlRKeXNyT3hLRTBoeUZqdTExSmhoZlRhUDZyWURuY1hYT256elRIek5UOG5kUDI4R3p1dzkxWHB3ZE9DUWh6Yl9RTkl2aWJPV2FDd2x4MktST1NBZjY5SDlVYUR6REdJcFBCaFkyMjhqb0ZHZVBBSFdMZGRlZi1wVGpwOHBxUklROU1TRENhQ3lwTjdCMmVXS3kwek02d2tKZDh5LUtDVFRvdjNvN2pJdnNPeXV0T1A1?oc=5","date":"2025-12-11","type":"pipeline","source":"Seeking Alpha","summary":"Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On Sidelines (GERN) - Seeking Alpha","headline":"Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On Sidelines (GERN)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-27","type":"pipeline","source":"simplywall.st","summary":"Great week for Geron Corporation (NASDAQ:GERN) institutional investors after losing 71% over the previous year - simplywall.st","headline":"Great week for Geron Corporation (NASDAQ:GERN) institutional investors after losing 71% over the previous year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOWTV3dnF0X1puSVBSNE56ZXZCQmNDZzZuaWNSckxQRWdzYURMVHRxbHdlT2s2V2J5dng0U1IzZS12R2hEdm5KTW0yTllZMzFzeWh5bWJfMkdhOUk5SXNUcERsNEdzd01LbF9WdmFKZHQ0aG1RcU00SkpEakhteTA0a2VUR3VHT1UtTUdDaw?oc=5","date":"2025-11-12","type":"pipeline","source":"Pharma Voice","summary":"After a lackluster first drug launch, a new CEO is finding Geron’s commercial footing - Pharma Voice","headline":"After a lackluster first drug launch, a new CEO is finding Geron’s commercial footing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOFZISDF5U1l4YnVtMF9pX3dnYXA2V28zM3pFaTd0UE82Wl9sLTd3S1NRanFjS24ySXkzeWthbzBueVp5d3N1NGFzMzNjcHVCd0pYeUZiSUZiWjhTZm84QzRBTXFNd3F5dmJ3cGNFbEk1Vmg4MFJhQ2s5OUFENUM0cUJUdV9NeVV1MmxGLWxleVVTQTBNQmhJVXFhd1pMSWp1OUVHWkpkSHQ4QkFGOUNLRUZhQlJhMndZR0FxT2tJcDIxZw?oc=5","date":"2025-10-13","type":"pipeline","source":"Investing.com","summary":"Geron announces leadership changes as part of strategic realignment - Investing.com","headline":"Geron announces leadership changes as part of strategic realignment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPdFVOUFRyM0Fnb3EyYWtqZ1duZGhmMUxaaVA3LXEwYlBSOVBoSmhUWnYwV1ItbEZ6Qmh6QXY0U2tiSUhFY0VGOGRvOFVEZmlvSWNrNWpSck1KVVpCTUhsSWtfWVVaTjJhdWxtdGg5ajl3RC1SX3JkWFNUcnpNM05DMlQ2V2s4SWcxdF9VUw?oc=5","date":"2025-08-28","type":"pipeline","source":"Yahoo Finance","summary":"Next Generation Drug Conjugates Market Report 2025-2035, with Profiles of Advanced Accelerator Applications, Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Geron, & Ionis Pharmaceuticals","headline":"Next Generation Drug Conjugates Market Report 2025-2035, with Profiles of Advanced Accelerator Applications, Alnylam Pha","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-20","type":"pipeline","source":"simplywall.st","summary":"Market Sentiment Around Loss-Making Geron Corporation (NASDAQ:GERN) - simplywall.st","headline":"Market Sentiment Around Loss-Making Geron Corporation (NASDAQ:GERN)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":1065000,"revenuePeriod":"2017-12-31","revenueHistory":[{"value":1065000,"period":"2017-12-31"},{"value":191000,"period":"2017-12-31"},{"value":163000,"period":"2017-09-30"},{"value":174000,"period":"2017-06-30"},{"value":537000,"period":"2017-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-83500000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":570540000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}